2018
DOI: 10.1111/bjd.16570
|View full text |Cite
|
Sign up to set email alerts
|

Cover Image: Neuroendocrine treatment of inherited keratin disorders by cannabinoids?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
17
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
6
1
1

Relationship

2
6

Authors

Journals

citations
Cited by 16 publications
(17 citation statements)
references
References 2 publications
0
17
0
Order By: Relevance
“…As reviewed above, the CB 1 agonist ACEA increased K10 expression, while reducing K1 production in human epidermis in culture [69]. Such changes could potentially be harnessed in epidermolytic ichthyosis patients to decrease the expression of mutated K1 while upregulating the expression of K10 that can functionally compensate in part for the mutated keratin.…”
Section: Treatment Of Keratin-related Skin and Hair Genetic Disordersmentioning
confidence: 92%
See 1 more Smart Citation
“…As reviewed above, the CB 1 agonist ACEA increased K10 expression, while reducing K1 production in human epidermis in culture [69]. Such changes could potentially be harnessed in epidermolytic ichthyosis patients to decrease the expression of mutated K1 while upregulating the expression of K10 that can functionally compensate in part for the mutated keratin.…”
Section: Treatment Of Keratin-related Skin and Hair Genetic Disordersmentioning
confidence: 92%
“…When tested in human skin culture and again in HaCaT cells, anandamide also inhibited K6 and K16 expression, independent of its antiproliferative properties [68]. Conversely, administration of the CB 1 antagonist, arachidonyl-2′-chloroethylamide (ACEA), upregulated K10 in human epidermis while decreasing the expression of K1 ex vivo [69].…”
Section: The Effects Of Endocannabinoids On Keratin Expressionmentioning
confidence: 99%
“…The samples were obtained with informed patient consent and approval from the University of Muenster Ethics Committee, adhering to Helsinki guidelines. The samples were prepared as 4‐mm punch samples and used for full‐thickness human skin organ culture serum‐free conditions as described previously . The samples were kept free‐floating in serum‐free medium.…”
Section: Methodsmentioning
confidence: 99%
“…Keratinization disorders result from mutations in one of the keratin genes, resulting in inherited skin or hair disorders, based on the expression pattern of the mutated keratin. 70,115,116 Since keratins form intermediate filaments by forming a heterodimer pair of keratins, it has been postulated that this keratin-modulating effect can be harnessed to upregulate the expression of non-mutated keratin genes or keratins that can compensate for the mutated, functionally defective keratin gene product and/or downregulate the mutated keratins. 70,115,116 This may suffice to counteract, at least in part, some of the functional defects imparted by the mutated keratin.…”
Section: Keratinization Disordersmentioning
confidence: 99%
“…70,115,116 Since keratins form intermediate filaments by forming a heterodimer pair of keratins, it has been postulated that this keratin-modulating effect can be harnessed to upregulate the expression of non-mutated keratin genes or keratins that can compensate for the mutated, functionally defective keratin gene product and/or downregulate the mutated keratins. 70,115,116 This may suffice to counteract, at least in part, some of the functional defects imparted by the mutated keratin. For example, the stimulatory effect of TH on K15 might be beneficial in patients with K14 mutations associated with epidermolysis bullosa simplex, since K15 can substitute for the mutated K14 in forming keratin pairs with K5.…”
Section: Keratinization Disordersmentioning
confidence: 99%